This is fantastic news, but they kind of buried the lede here:
A separate study looking at a new slimming jab has found that it could be much more effective than those already on the market. Retatrutide, a weekly injection, works by suppressing appetite and also by helping the body burn more fat, according to its phase 2 clinical trial.
The trial of 338 participants living with obesity showed that participants lost 24% of their body weight over a 48-week period. [emphasis added] Researchers say it is more effective for weight loss than Ozempic or Wegovy, which only work by suppressing appetite.
That's a quarter of a person's mass in less than a year. For persons with obesity, that's absolutely insane. It's better than gastric bypass surgery (and depending on your perspective, comparing risk of complications, long-term compliance requirements, and potential side effects, semaglutide already is). It would be like taking semaglutide and also taking meth for a year, but without ruining your life.
Now if only the taxpayers who paid for the research owned the patent. ...